Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: Sustained Ketamine Effectiveness for Suicidal Ideation

View source ↗

Summary

A completed clinical trial suggests ketamine provides sustained reduction in suicidal ideation in individuals with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Depression - Major Depressive Disorder, Suicide | Status: COMPLETED